Takahiro Sato

Sapporo, 0608638, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

1064 nm-absorbing semiconducting polymer nanoparticles for multimodal photoacoustic and fluorescence imaging.

1064 nm-absorbing semiconducting polymer nanoparticles for multimodal photoacoustic and fluorescence imaging.

Journal: Biomedical optics express
Published: May 11, 2026

Efficacy of short-term, low-dose pulmonary vasodilators for chronic thromboembolic pulmonary hypertension: a retrospective pilot study.

Efficacy of short-term, low-dose pulmonary vasodilators for chronic thromboembolic pulmonary hypertension: a retrospective pilot study.

Journal: Respiratory investigation
Published: March 26, 2026

Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance-proven cardiac involvement in pulmonary sarcoidosis: a single centre long-term cohort study.

Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance-proven cardiac involvement in pulmonary sarcoidosis: a single centre long-term cohort study.

Journal: BMC pulmonary medicine
Published: March 02, 2026

Interpretation of myocardial FDG uptake during corticosteroid therapy in cardiac sarcoidosis evaluation with 18F-FDG PET/CT.

Interpretation of myocardial FDG uptake during corticosteroid therapy in cardiac sarcoidosis evaluation with 18F-FDG PET/CT.

Journal: Annals of nuclear medicine
Published: February 13, 2026

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography one month after initiation of prednisolone therapy in patients with cardiac sarcoidosis.

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography one month after initiation of prednisolone therapy in patients with cardiac sarcoidosis.

Journal: International journal of cardiology
Published: October 27, 2025

Right Ventricular Dysfunction in Lung Disease/Hypoxia-Associated Pulmonary Hypertension.

Right Ventricular Dysfunction in Lung Disease/Hypoxia-Associated Pulmonary Hypertension.

Journal: Journal of the American Heart Association
Published: August 12, 2025

Pathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension.

Pathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension.

Journal: Respiratory medicine
Published: April 23, 2025

Two cases of bronchial artery aneurysms in patients with long-standing precapillary pulmonary hypertension.

Two cases of bronchial artery aneurysms in patients with long-standing precapillary pulmonary hypertension.

Journal: Respiratory investigation
Published: March 25, 2025

Targeted theranostic nanomedicine using targeted CT-imageable particles that release tebentafusp.

Targeted theranostic nanomedicine using targeted CT-imageable particles that release tebentafusp.

Journal: Japanese journal of radiology
Published: January 16, 2025

Prevalence, incidence, and clinical features of cardiac involvement in patients with pulmonary sarcoidosis.

Prevalence, incidence, and clinical features of cardiac involvement in patients with pulmonary sarcoidosis.

Journal: Respiratory medicine
Published: November 12, 2024

Reduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology.

Reduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology.

Journal: Respiratory investigation
Published: September 25, 2024

Automatic pacing output optimization system causes pacing failure: Two case reports.

Automatic pacing output optimization system causes pacing failure: Two case reports.

Journal: HeartRhythm case reports
Published: May 27, 2024
Showing 1-12 of 55

Last Updated: 09/26/2026